Skip to content
10-Q

Quarterly Report

US-China Biomedical Technology, Inc.

0001683168-18-001957

← back to feed
Filed
Jul 16, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Jul 16, 2018 15.51M sh
Cash And Equivalents Q1 2019 · May 31, 2018 $459.48K
Cash And Equivalents Q1 2019 · Feb 28, 2018 $56.41K
Total Liabilities Q1 2019 · May 31, 2018 $58.69K
Total Liabilities Q1 2019 · Feb 28, 2018 $352.43K
Current Assets Q1 2019 · May 31, 2018 $477.18K
Current Assets Q1 2019 · Feb 28, 2018 $61.41K
Total Assets Q1 2019 · May 31, 2018 $496.4K
Total Assets Q1 2019 · Feb 28, 2018 $80.63K
Operating Cash Flow Q1 2019 · May 31, 2017 −$1.96K
Sga Expense Q1 2019 · May 31, 2017 $40.03K
Net Income Q1 2019 · May 31, 2017 −$40.03K